Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, January 31, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bringing Customers a New Web Experience - Alfa Aesar Launches Redesigned Website
Thursday, January 29, 2015
The redesign provides a fresh new layout and offers improved intuitive navigation with a high degree of user-friendliness.

Analytik Announces the Launch of the Sentronic Handheld NIR Analyzer
Wednesday, January 28, 2015
SentroID for the fast identification and composition analysis of plastics and polymers.

Renishaw to Exhibit at Pittcon 2015
Wednesday, January 28, 2015
Company adds to the comprehensive imaging options available with its inVia confocal Raman microscope.

Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer
Saturday, January 24, 2015
Offers comprehensive measurement options in a compact body.

Rigaku Publishes New Application Report
Saturday, December 27, 2014
Analysis of sulfur and ultra-low chlorine in crude oil.

Bruker Releases ONET Software
Thursday, December 18, 2014
New networking software for administration of FT-NIR spectrometer networks.

ONET Software Released
Wednesday, December 17, 2014
Bruker releases ONET Software for administration of FT-NIR spectrometer networks.

Rigaku Publishes New Method for Silicate Rock Analysis
Friday, December 12, 2014
Analysis by fusion using Rigaku ZSX Primus III+ WDXRF.

WITec Refreshes its Website www.witec.de
Tuesday, December 09, 2014
The webpage includes new features to broaden the spectrum of the website.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 546
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn